Project N95

Analysis

Project N95 is a registered charity in United States, based in New York, NY. It received its IRS tax-exemption ruling in July 2020, 6 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (donations from the general public) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Project N95 reported income of $621k and spending of $1.9m, spending 312% of what it took in. Across the 4 years on record, from December 2020 to December 2023, income fell from $1.2m to $621k (-46%), an average of -19% a year. The sharpest change came in the year to December 2021, when income rose by 174%. Over the whole period it spent 94% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Project N95 sits at the 58th percentile: it is larger than about 58% of them. Against every charity in United States with reported income it ranks in the 73rd percentile, and in the 69th percentile within NY. Charities of a similar size with the same main cause include Louvenia D Barksdale Sickle Cell Anemia Foundation Inc ($621k), Pediatric Oncology Support Team Inc ($621k) and Bethany Home Foundation ($621k).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 13% and program service revenue 84% of the total. Compensation of current officers, directors and key employees was $97k (5.0% of expenses). Other salaries and wages came to $160k. At year end it held assets of $622k against liabilities of $622k, net assets of $0. It reported 3 employees.